Brief: Lee's Pharmaceutical Says Investigational NDA Of Staccato Fentanyl Accepted By NMPA
31/08/2020 16:06
Aug 31 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* UNIT'S INVESTIGATIONAL NEW DRUG APPLICATION OF STACCATO
FENTANYL
ACCEPTED BY NMPA
Source text for Eikon: urn:newsml:reuters.com:*:nHKS5DZC0B
Further company coverage: 0950.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA